Loading…

Specific inhibitors of tyrosine-specific protein kinases: properties of 4-hydroxycinnamamide derivatives in vitro

Inhibition by seven synthetic 4-hydroxycinnamamide derivatives, ST 271, ST 280, ST 458, ST 494, ST 633, ST 638, and ST 642, of tyrosine-specific protein kinases (tyrosine kinase) of oncogene or proto-oncogene products (p130gag-v-fps, p70gag-actin-v-fgr, pp60v-src, pp60c-src) and epidermal growth fac...

Full description

Saved in:
Bibliographic Details
Published in:Cancer research (Chicago, Ill.) Ill.), 1989-05, Vol.49 (9), p.2374-2378
Main Authors: SHIRAISHI, T, OWADA, M. K, TATSUKA, M, YAMASHITA, T, WATANABE, K, KAKUNAGA, T
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 2378
container_issue 9
container_start_page 2374
container_title Cancer research (Chicago, Ill.)
container_volume 49
creator SHIRAISHI, T
OWADA, M. K
TATSUKA, M
YAMASHITA, T
WATANABE, K
KAKUNAGA, T
description Inhibition by seven synthetic 4-hydroxycinnamamide derivatives, ST 271, ST 280, ST 458, ST 494, ST 633, ST 638, and ST 642, of tyrosine-specific protein kinases (tyrosine kinase) of oncogene or proto-oncogene products (p130gag-v-fps, p70gag-actin-v-fgr, pp60v-src, pp60c-src) and epidermal growth factor (EGF) receptor kinase were investigated. ST 638 (alpha-cyano-3-ethoxy-4-hydroxy-5-phenylthiomethylcinnamamide) strongly inhibited more of the tyrosine kinases than any of the other compounds. The susceptibilities of these tyrosine kinases to ST 638 increased in the following order: EGF receptor greater than p70gag-actin-v-fgr greater than pp60c-src greater than p130gag-v-fps, pp60v-src, with 50% inhibitory concentration values of 1.1, 4.2, 18, 70, and 87 microM, respectively. The phosphorylation of the tyrosine residues in particulate fractions from RR1022 cells expressing pp60v-src was inhibited by ST 638 in a dose-dependent way, while it had a negligible effect on the phosphorylations of threonine and serine residues. Kinetic analysis showed that ST 638 competitively inhibited the phosphorylation of an exogenous substrate by the EGF receptor kinase with a Ki of 2.1 microM. ST 638 noncompetitively inhibited autophosphorylation by EGF receptor kinase. These results indicate that ST 638 is a potent and specific inhibitor of tyrosine kinases in vitro, and that its inhibitory activity is caused by competing with the substrate protein for the tyrosine kinase binding site.
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_76288944</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>15221071</sourcerecordid><originalsourceid>FETCH-LOGICAL-h214t-a92500bddbd81e910d6d0fc65a40be2e0ec6aba9a3e2a617ca79120ea1a482723</originalsourceid><addsrcrecordid>eNqFkE1LxDAQhoMo67r6E4QexFshSZOm9SaLXyB4UM9lmkzZ0X5t0l3sv7dq9eppmHmedxjmgC2FTrLYKKUP2ZJznsVaGXnMTkJ4m1otuF6whTQ8TaVesu1zj5YqshG1Gypp6HyIuioaRt8FajEOv7z33YDURu_UQsBw9TXo0Q-E3wEVb0bnu4_RUttCAw05jBx62sNA-8mZonsafHfKjiqoA57NdcVeb29e1vfx49Pdw_r6Md5IoYYYcqk5L50rXSYwF9yljlc21aB4iRI52hRKyCFBCakwFkwuJEcQoDJpZLJilz97pzu3OwxD0VCwWNfQYrcLhUllluVK_SsKLaXgRkzi-SzuygZd0XtqwI_F_MyJX8wcgoW68tBaCn-aSYRMjUo-AYNNgNo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>15221071</pqid></control><display><type>article</type><title>Specific inhibitors of tyrosine-specific protein kinases: properties of 4-hydroxycinnamamide derivatives in vitro</title><source>EZB Electronic Journals Library</source><creator>SHIRAISHI, T ; OWADA, M. K ; TATSUKA, M ; YAMASHITA, T ; WATANABE, K ; KAKUNAGA, T</creator><creatorcontrib>SHIRAISHI, T ; OWADA, M. K ; TATSUKA, M ; YAMASHITA, T ; WATANABE, K ; KAKUNAGA, T</creatorcontrib><description>Inhibition by seven synthetic 4-hydroxycinnamamide derivatives, ST 271, ST 280, ST 458, ST 494, ST 633, ST 638, and ST 642, of tyrosine-specific protein kinases (tyrosine kinase) of oncogene or proto-oncogene products (p130gag-v-fps, p70gag-actin-v-fgr, pp60v-src, pp60c-src) and epidermal growth factor (EGF) receptor kinase were investigated. ST 638 (alpha-cyano-3-ethoxy-4-hydroxy-5-phenylthiomethylcinnamamide) strongly inhibited more of the tyrosine kinases than any of the other compounds. The susceptibilities of these tyrosine kinases to ST 638 increased in the following order: EGF receptor greater than p70gag-actin-v-fgr greater than pp60c-src greater than p130gag-v-fps, pp60v-src, with 50% inhibitory concentration values of 1.1, 4.2, 18, 70, and 87 microM, respectively. The phosphorylation of the tyrosine residues in particulate fractions from RR1022 cells expressing pp60v-src was inhibited by ST 638 in a dose-dependent way, while it had a negligible effect on the phosphorylations of threonine and serine residues. Kinetic analysis showed that ST 638 competitively inhibited the phosphorylation of an exogenous substrate by the EGF receptor kinase with a Ki of 2.1 microM. ST 638 noncompetitively inhibited autophosphorylation by EGF receptor kinase. These results indicate that ST 638 is a potent and specific inhibitor of tyrosine kinases in vitro, and that its inhibitory activity is caused by competing with the substrate protein for the tyrosine kinase binding site.</description><identifier>ISSN: 0008-5472</identifier><identifier>EISSN: 1538-7445</identifier><identifier>PMID: 2706625</identifier><identifier>CODEN: CNREA8</identifier><language>eng</language><publisher>Philadelphia, PA: American Association for Cancer Research</publisher><subject>4-hydroxycinnamamide ; Adenosine Triphosphate - metabolism ; Analytical, structural and metabolic biochemistry ; Animals ; Binding, Competitive ; Biological and medical sciences ; Cinnamates - pharmacology ; Coumaric Acids - pharmacology ; Enzymes and enzyme inhibitors ; ErbB Receptors - metabolism ; Fundamental and applied biological sciences. Psychology ; Humans ; Kinetics ; oncogenes ; oncoproteins ; Phosphorylation ; Propionates ; Protein-Tyrosine Kinases - antagonists &amp; inhibitors ; Transferases</subject><ispartof>Cancer research (Chicago, Ill.), 1989-05, Vol.49 (9), p.2374-2378</ispartof><rights>1989 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=7312674$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2706625$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>SHIRAISHI, T</creatorcontrib><creatorcontrib>OWADA, M. K</creatorcontrib><creatorcontrib>TATSUKA, M</creatorcontrib><creatorcontrib>YAMASHITA, T</creatorcontrib><creatorcontrib>WATANABE, K</creatorcontrib><creatorcontrib>KAKUNAGA, T</creatorcontrib><title>Specific inhibitors of tyrosine-specific protein kinases: properties of 4-hydroxycinnamamide derivatives in vitro</title><title>Cancer research (Chicago, Ill.)</title><addtitle>Cancer Res</addtitle><description>Inhibition by seven synthetic 4-hydroxycinnamamide derivatives, ST 271, ST 280, ST 458, ST 494, ST 633, ST 638, and ST 642, of tyrosine-specific protein kinases (tyrosine kinase) of oncogene or proto-oncogene products (p130gag-v-fps, p70gag-actin-v-fgr, pp60v-src, pp60c-src) and epidermal growth factor (EGF) receptor kinase were investigated. ST 638 (alpha-cyano-3-ethoxy-4-hydroxy-5-phenylthiomethylcinnamamide) strongly inhibited more of the tyrosine kinases than any of the other compounds. The susceptibilities of these tyrosine kinases to ST 638 increased in the following order: EGF receptor greater than p70gag-actin-v-fgr greater than pp60c-src greater than p130gag-v-fps, pp60v-src, with 50% inhibitory concentration values of 1.1, 4.2, 18, 70, and 87 microM, respectively. The phosphorylation of the tyrosine residues in particulate fractions from RR1022 cells expressing pp60v-src was inhibited by ST 638 in a dose-dependent way, while it had a negligible effect on the phosphorylations of threonine and serine residues. Kinetic analysis showed that ST 638 competitively inhibited the phosphorylation of an exogenous substrate by the EGF receptor kinase with a Ki of 2.1 microM. ST 638 noncompetitively inhibited autophosphorylation by EGF receptor kinase. These results indicate that ST 638 is a potent and specific inhibitor of tyrosine kinases in vitro, and that its inhibitory activity is caused by competing with the substrate protein for the tyrosine kinase binding site.</description><subject>4-hydroxycinnamamide</subject><subject>Adenosine Triphosphate - metabolism</subject><subject>Analytical, structural and metabolic biochemistry</subject><subject>Animals</subject><subject>Binding, Competitive</subject><subject>Biological and medical sciences</subject><subject>Cinnamates - pharmacology</subject><subject>Coumaric Acids - pharmacology</subject><subject>Enzymes and enzyme inhibitors</subject><subject>ErbB Receptors - metabolism</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Humans</subject><subject>Kinetics</subject><subject>oncogenes</subject><subject>oncoproteins</subject><subject>Phosphorylation</subject><subject>Propionates</subject><subject>Protein-Tyrosine Kinases - antagonists &amp; inhibitors</subject><subject>Transferases</subject><issn>0008-5472</issn><issn>1538-7445</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1989</creationdate><recordtype>article</recordtype><recordid>eNqFkE1LxDAQhoMo67r6E4QexFshSZOm9SaLXyB4UM9lmkzZ0X5t0l3sv7dq9eppmHmedxjmgC2FTrLYKKUP2ZJznsVaGXnMTkJ4m1otuF6whTQ8TaVesu1zj5YqshG1Gypp6HyIuioaRt8FajEOv7z33YDURu_UQsBw9TXo0Q-E3wEVb0bnu4_RUttCAw05jBx62sNA-8mZonsafHfKjiqoA57NdcVeb29e1vfx49Pdw_r6Md5IoYYYcqk5L50rXSYwF9yljlc21aB4iRI52hRKyCFBCakwFkwuJEcQoDJpZLJilz97pzu3OwxD0VCwWNfQYrcLhUllluVK_SsKLaXgRkzi-SzuygZd0XtqwI_F_MyJX8wcgoW68tBaCn-aSYRMjUo-AYNNgNo</recordid><startdate>19890501</startdate><enddate>19890501</enddate><creator>SHIRAISHI, T</creator><creator>OWADA, M. K</creator><creator>TATSUKA, M</creator><creator>YAMASHITA, T</creator><creator>WATANABE, K</creator><creator>KAKUNAGA, T</creator><general>American Association for Cancer Research</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7QL</scope><scope>7TO</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>M81</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>19890501</creationdate><title>Specific inhibitors of tyrosine-specific protein kinases: properties of 4-hydroxycinnamamide derivatives in vitro</title><author>SHIRAISHI, T ; OWADA, M. K ; TATSUKA, M ; YAMASHITA, T ; WATANABE, K ; KAKUNAGA, T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-h214t-a92500bddbd81e910d6d0fc65a40be2e0ec6aba9a3e2a617ca79120ea1a482723</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1989</creationdate><topic>4-hydroxycinnamamide</topic><topic>Adenosine Triphosphate - metabolism</topic><topic>Analytical, structural and metabolic biochemistry</topic><topic>Animals</topic><topic>Binding, Competitive</topic><topic>Biological and medical sciences</topic><topic>Cinnamates - pharmacology</topic><topic>Coumaric Acids - pharmacology</topic><topic>Enzymes and enzyme inhibitors</topic><topic>ErbB Receptors - metabolism</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Humans</topic><topic>Kinetics</topic><topic>oncogenes</topic><topic>oncoproteins</topic><topic>Phosphorylation</topic><topic>Propionates</topic><topic>Protein-Tyrosine Kinases - antagonists &amp; inhibitors</topic><topic>Transferases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>SHIRAISHI, T</creatorcontrib><creatorcontrib>OWADA, M. K</creatorcontrib><creatorcontrib>TATSUKA, M</creatorcontrib><creatorcontrib>YAMASHITA, T</creatorcontrib><creatorcontrib>WATANABE, K</creatorcontrib><creatorcontrib>KAKUNAGA, T</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biochemistry Abstracts 3</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer research (Chicago, Ill.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>SHIRAISHI, T</au><au>OWADA, M. K</au><au>TATSUKA, M</au><au>YAMASHITA, T</au><au>WATANABE, K</au><au>KAKUNAGA, T</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Specific inhibitors of tyrosine-specific protein kinases: properties of 4-hydroxycinnamamide derivatives in vitro</atitle><jtitle>Cancer research (Chicago, Ill.)</jtitle><addtitle>Cancer Res</addtitle><date>1989-05-01</date><risdate>1989</risdate><volume>49</volume><issue>9</issue><spage>2374</spage><epage>2378</epage><pages>2374-2378</pages><issn>0008-5472</issn><eissn>1538-7445</eissn><coden>CNREA8</coden><abstract>Inhibition by seven synthetic 4-hydroxycinnamamide derivatives, ST 271, ST 280, ST 458, ST 494, ST 633, ST 638, and ST 642, of tyrosine-specific protein kinases (tyrosine kinase) of oncogene or proto-oncogene products (p130gag-v-fps, p70gag-actin-v-fgr, pp60v-src, pp60c-src) and epidermal growth factor (EGF) receptor kinase were investigated. ST 638 (alpha-cyano-3-ethoxy-4-hydroxy-5-phenylthiomethylcinnamamide) strongly inhibited more of the tyrosine kinases than any of the other compounds. The susceptibilities of these tyrosine kinases to ST 638 increased in the following order: EGF receptor greater than p70gag-actin-v-fgr greater than pp60c-src greater than p130gag-v-fps, pp60v-src, with 50% inhibitory concentration values of 1.1, 4.2, 18, 70, and 87 microM, respectively. The phosphorylation of the tyrosine residues in particulate fractions from RR1022 cells expressing pp60v-src was inhibited by ST 638 in a dose-dependent way, while it had a negligible effect on the phosphorylations of threonine and serine residues. Kinetic analysis showed that ST 638 competitively inhibited the phosphorylation of an exogenous substrate by the EGF receptor kinase with a Ki of 2.1 microM. ST 638 noncompetitively inhibited autophosphorylation by EGF receptor kinase. These results indicate that ST 638 is a potent and specific inhibitor of tyrosine kinases in vitro, and that its inhibitory activity is caused by competing with the substrate protein for the tyrosine kinase binding site.</abstract><cop>Philadelphia, PA</cop><pub>American Association for Cancer Research</pub><pmid>2706625</pmid><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0008-5472
ispartof Cancer research (Chicago, Ill.), 1989-05, Vol.49 (9), p.2374-2378
issn 0008-5472
1538-7445
language eng
recordid cdi_proquest_miscellaneous_76288944
source EZB Electronic Journals Library
subjects 4-hydroxycinnamamide
Adenosine Triphosphate - metabolism
Analytical, structural and metabolic biochemistry
Animals
Binding, Competitive
Biological and medical sciences
Cinnamates - pharmacology
Coumaric Acids - pharmacology
Enzymes and enzyme inhibitors
ErbB Receptors - metabolism
Fundamental and applied biological sciences. Psychology
Humans
Kinetics
oncogenes
oncoproteins
Phosphorylation
Propionates
Protein-Tyrosine Kinases - antagonists & inhibitors
Transferases
title Specific inhibitors of tyrosine-specific protein kinases: properties of 4-hydroxycinnamamide derivatives in vitro
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T10%3A31%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Specific%20inhibitors%20of%20tyrosine-specific%20protein%20kinases:%20properties%20of%204-hydroxycinnamamide%20derivatives%20in%20vitro&rft.jtitle=Cancer%20research%20(Chicago,%20Ill.)&rft.au=SHIRAISHI,%20T&rft.date=1989-05-01&rft.volume=49&rft.issue=9&rft.spage=2374&rft.epage=2378&rft.pages=2374-2378&rft.issn=0008-5472&rft.eissn=1538-7445&rft.coden=CNREA8&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E15221071%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-h214t-a92500bddbd81e910d6d0fc65a40be2e0ec6aba9a3e2a617ca79120ea1a482723%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=15221071&rft_id=info:pmid/2706625&rfr_iscdi=true